Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Fujifilm, Reddy’s Form Generics Venture

by Jean-François Tremblay
August 8, 2011 | A version of this story appeared in Volume 89, Issue 32

Fujifilm and Dr. Reddy’s Laboratories have agreed to form a joint venture to develop and sell generic pharmaceuticals in Japan. The new unit will be owned 51% by Fujifilm and 49% by Dr. Reddy’s. Japan is the world’s second-largest market for generic drugs, yet less than a quarter of Japanese doctors’ prescriptions are for generic drugs, the companies note. In the U.S., more than two-thirds of prescriptions are for generics, the firms add.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.